Outcome of Patients With Metastatic Chromophobe Renal Cell Carcinoma Treated With Sunitinib

BACKGROUND. Sunitinib is a standard treatment for metastatic clear cell renal cell carcinoma (mccRCC). Data on its activity in the rare variant of metastatic chromophobe renal cell carcinoma (mchRCC), are limited. We aimed to analyze the activity of sunitinib in a relatively large and homogenous int...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncologist
Glavni autori: Keizman, Daniel, Sarid, David, Lee, Jae L., Sella, Avishay, Gottfried, Maya, Hammers, Hans, Eisenberger, Mario A., Carducci, Michael A., Sinibaldi, Victoria, Neiman, Victoria, Rosenbaum, Eli, Peer, Avivit, Neumann, Avivit, Mermershtain, Wilmosh, Rouvinov, Keren, Berger, Raanan, Yildiz, Ibrahim
Format: Artigo
Jezik:Inglês
Izdano: AlphaMed Press 2016
Teme:
Genitourinary Cancer
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5061527/
https://ncbi.nlm.nih.gov/pubmed/27382030
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0428
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items